Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study.
Heidi E KosiorekRobyn M ScherberHolly L GeyerSrdan VerstovsekBlake T LanglaisGina L MazzaJason GotlibVikas K GuptaLeslie J PadrnosJeanne M PalmerAngela FleischmanRuben A MesaAmylou C DueckPublished in: British journal of haematology (2022)
Keyphrases